Ganglioglioma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ganglioglioma}} | {{Ganglioglioma}} | ||
{{CMG}}{{AE}}{{SR}} | |||
==Overview== | |||
==Medical therapy== | |||
[[Radiotherapy]] or [[chemotherapy]] is not the first-line treatment option for patients with gangliogliomas. [[Radiation therapy]] is usually reserved for patients when either incomplete [[resection]] is achievable, or tumor recurrence occurs. | |||
==References== | ==References== | ||
Revision as of 15:39, 4 September 2015
|
Ganglioglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ganglioglioma medical therapy On the Web |
|
American Roentgen Ray Society Images of Ganglioglioma medical therapy |
|
Risk calculators and risk factors for Ganglioglioma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Medical therapy
Radiotherapy or chemotherapy is not the first-line treatment option for patients with gangliogliomas. Radiation therapy is usually reserved for patients when either incomplete resection is achievable, or tumor recurrence occurs.